Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.540
-0.026 (-1.66%)
Jun 3, 2026, 5:35 PM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €146.94 million as of June 3, 2026. Its market cap has decreased by -18.74% in one year.
Market Cap
146.94M
Enterprise Value
135.20M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.54
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 146.94M, an increase of 18,449.78%. That is a compound annual growth rate of 30.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 146.94M | -0.50% |
| Dec 31, 2025 | 147.67M | -7.67% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 475.44M |
| Genfit | 426.75M |
| Transgene | 223.49M |
| Sensorion | 222.10M |
| Cellectis | 219.69M |
| ABIONYX Pharma | 99.88M |
| Valerio Therapeutics Société anonyme | 95.79M |
| Adocia | 94.32M |